Everett Harris & Co. CA Trims Stock Holdings in Colgate-Palmolive (NYSE:CL)

Everett Harris & Co. CA lessened its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 0.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 786,595 shares of the company's stock after selling 5,396 shares during the period. Colgate-Palmolive accounts for about 1.0% of Everett Harris & Co. CA's investment portfolio, making the stock its 23rd biggest holding. Everett Harris & Co. CA owned approximately 0.10% of Colgate-Palmolive worth $81,656,000 as of its most recent filing with the SEC.

Other hedge funds have also recently made changes to their positions in the company. Diversify Advisory Services LLC purchased a new stake in shares of Colgate-Palmolive in the first quarter worth about $911,000. TD Asset Management Inc lifted its position in shares of Colgate-Palmolive by 2.4% in the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company's stock worth $103,969,000 after buying an additional 26,987 shares in the last quarter. Empowered Funds LLC lifted its position in shares of Colgate-Palmolive by 277.3% in the first quarter. Empowered Funds LLC now owns 33,082 shares of the company's stock worth $2,979,000 after buying an additional 24,314 shares in the last quarter. M&G Plc purchased a new stake in Colgate-Palmolive during the first quarter valued at approximately $3,812,000. Finally, Sei Investments Co. raised its position in Colgate-Palmolive by 41.5% during the first quarter. Sei Investments Co. now owns 598,639 shares of the company's stock valued at $53,901,000 after purchasing an additional 175,445 shares during the period. Institutional investors own 80.41% of the company's stock.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and upped their price objective for the company from $107.00 to $109.00 in a research report on Monday, September 9th. Hsbc Global Res downgraded Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 26th. Stifel Nicolaus upped their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the company a "buy" rating in a research report on Monday, July 22nd. Wells Fargo & Company downgraded Colgate-Palmolive from an "equal weight" rating to an "underweight" rating and set a $100.00 price target on the stock. in a report on Monday, September 16th. Finally, Morgan Stanley increased their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an "overweight" rating in a report on Monday, July 29th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $106.00.

Colgate-Palmolive Stock Up 0.4 %

NYSE CL traded up $0.43 during midday trading on Friday, hitting $100.46. 4,502,563 shares of the company traded hands, compared to its average volume of 4,340,555. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The company has a market cap of $82.42 billion, a PE ratio of 31.79, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. The company's 50-day simple moving average is $103.43 and its 200-day simple moving average is $97.54. Colgate-Palmolive has a 52 week low of $71.46 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to analysts' expectations of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business's revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.77 EPS. As a group, equities research analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 1.99%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 63.29%.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider Sally Massey sold 15,850 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, insider Sally Massey sold 15,850 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Gregory Malcolm sold 10,533 shares of the stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total value of $1,085,952.30. Following the sale, the executive vice president now owns 10,377 shares of the company's stock, valued at approximately $1,069,868.70. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 43,490 shares of company stock valued at $4,486,063. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.